NCT04536207

Brief Summary

This study aimed to assess the efficacy of cryotherapy in controlling Peripheral Neuropathy in cancer children

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable cancer

Timeline
Completed

Started Feb 2022

Shorter than P25 for not_applicable cancer

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 16, 2020

Completed
17 days until next milestone

First Posted

Study publicly available on registry

September 2, 2020

Completed
1.4 years until next milestone

Study Start

First participant enrolled

February 1, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2022

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 15, 2022

Completed
Last Updated

October 15, 2021

Status Verified

October 1, 2021

Enrollment Period

5 months

First QC Date

August 16, 2020

Last Update Submit

October 13, 2021

Conditions

Keywords

CancerPeripheral neuropathyCryotherapy

Outcome Measures

Primary Outcomes (8)

  • Nerve conduction studies (NCS)

    nerve conduction velocity for sensory ulnar nerve

    nerve conduction velocity for sensory ulnar nerve at day 0

  • Nerve conduction studies (NCS)

    nerve conduction velocity for sensory ulnar nerve

    nerve conduction velocity for sensory ulnar nerve at day 90

  • Nerve conduction studies (NCS)

    nerve conduction velocity for sensory median nerve

    nerve conduction velocity for sensory sensory median nerve at day 0

  • Nerve conduction studies (NCS)

    nerve conduction velocity for sensory median nerve

    nerve conduction velocity for sensory sensory median nerve at day 90

  • Nerve conduction studies (NCS)

    nerve conduction velocity for sensory sural nerve

    nerve conduction velocity for sensory sural nerve at day 0

  • Nerve conduction studies (NCS)

    nerve conduction velocity for sensory sural nerve

    nerve conduction velocity for sensory sural nerve at day 90

  • Nerve conduction studies (NCS)

    nerve conduction velocity for motor common peroneal nerve

    nerve conduction velocity for motor common peroneal nerve at day 0

  • Nerve conduction studies (NCS)

    nerve conduction velocity for motor common peroneal nerve

    nerve conduction velocity for motor common peroneal nerve at day 90

Study Arms (2)

the study group

EXPERIMENTAL

Group (A) the study group received cryotherapy

Other: Cryotherapy (apparatus)

the control group

NO INTERVENTION

Group (B) the control group not received cryotherapy

Interventions

Cryotherapy is a pain treatment that uses a method of localized freezing temperatures to deaden an irritated nerve. Cryotherapy is also used as a method of treating localized areas of some cancers (called cryosurgery), such as prostate cancer and to treat abnormal skin cells by dermatologists

the study group

Eligibility Criteria

Age8 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Their age will ranging from eight to seventeen years.
  • Children participated in this study will from both sexes.
  • Children receiving chemotherapy as medical treatment protocol
  • All children have polyneuropathy caused by chemotherapy.

You may not qualify if:

  • Children with Epilepsy.
  • Children with blood clotting disorder.
  • Children have Open wounds / broken skin
  • Children with severe cardiac disease
  • Uncooperative patients.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

South Valley University, Faculty of Physical Therapy

Qina, 83523, Egypt

RECRUITING

Related Publications (6)

  • Seretny M, Currie GL, Sena ES, Ramnarine S, Grant R, MacLeod MR, Colvin LA, Fallon M. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis. Pain. 2014 Dec;155(12):2461-2470. doi: 10.1016/j.pain.2014.09.020. Epub 2014 Sep 23.

    PMID: 25261162BACKGROUND
  • Hershman DL, Lacchetti C, Dworkin RH, Lavoie Smith EM, Bleeker J, Cavaletti G, Chauhan C, Gavin P, Lavino A, Lustberg MB, Paice J, Schneider B, Smith ML, Smith T, Terstriep S, Wagner-Johnston N, Bak K, Loprinzi CL; American Society of Clinical Oncology. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2014 Jun 20;32(18):1941-67. doi: 10.1200/JCO.2013.54.0914. Epub 2014 Apr 14.

    PMID: 24733808BACKGROUND
  • Scotte F, Banu E, Medioni J, Levy E, Ebenezer C, Marsan S, Banu A, Tourani JM, Andrieu JM, Oudard S. Matched case-control phase 2 study to evaluate the use of a frozen sock to prevent docetaxel-induced onycholysis and cutaneous toxicity of the foot. Cancer. 2008 Apr 1;112(7):1625-31. doi: 10.1002/cncr.23333.

    PMID: 18286527BACKGROUND
  • Hanai A, Ishiguro H, Sozu T, Tsuda M, Yano I, Nakagawa T, Imai S, Hamabe Y, Toi M, Arai H, Tsuboyama T. Effects of Cryotherapy on Objective and Subjective Symptoms of Paclitaxel-Induced Neuropathy: Prospective Self-Controlled Trial. J Natl Cancer Inst. 2018 Feb 1;110(2):141-148. doi: 10.1093/jnci/djx178.

    PMID: 29924336BACKGROUND
  • Tsuyuki S, Senda N, Kanng Y, Yamaguchi A, Yoshibayashi H, Kikawa Y, Katakami N, Kato H, Hashimoto T, Okuno T, Yamauchi A, Inamoto T. Evaluation of the effect of compression therapy using surgical gloves on nanoparticle albumin-bound paclitaxel-induced peripheral neuropathy: a phase II multicenter study by the Kamigata Breast Cancer Study Group. Breast Cancer Res Treat. 2016 Nov;160(1):61-67. doi: 10.1007/s10549-016-3977-7. Epub 2016 Sep 12.

    PMID: 27620884BACKGROUND
  • Kadakia KC, Rozell SA, Butala AA, Loprinzi CL. Supportive cryotherapy: a review from head to toe. J Pain Symptom Manage. 2014 Jun;47(6):1100-15. doi: 10.1016/j.jpainsymman.2013.07.014. Epub 2013 Nov 7.

    PMID: 24210702BACKGROUND

MeSH Terms

Conditions

NeoplasmsPeripheral Nervous System Diseases

Interventions

Cryotherapy

Condition Hierarchy (Ancestors)

Neuromuscular DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Therapeutics

Study Officials

  • Nehad A. Abo-zaid, Ph.D

    South Valley University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Nehad A. Abo-Zaid, Ph.D

CONTACT

Mohammed E Ali, Ph.D student

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Single (Outcomes Assessor) Blinding process to participants and care providers was impossible due to the nature of intervention therapy. Data were analyzed by an impartial statistician (outcomes assessor), referring to each arm with an encoded name: Group A (control group) and Group B (study group).
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: They were assigned randomly into two equal groups.Group (A) study group received the same medical care and cryotherapy, three times / weak for three successful months. And group (B) control group received medical care and standard chemotherapy only.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of physical therapy, Department of Physical Therapy for Pediatrics, Faculty of Physical Therapy, South Valley University, Qena, Egypt.

Study Record Dates

First Submitted

August 16, 2020

First Posted

September 2, 2020

Study Start

February 1, 2022

Primary Completion

June 30, 2022

Study Completion

July 15, 2022

Last Updated

October 15, 2021

Record last verified: 2021-10

Data Sharing

IPD Sharing
Will not share

Locations